Stratasys SSYS recently announced the launch of a new software module – Digital Anatomy Creator – designed for its digital anatomy 3D printers to improve personalized healthcare through anatomical modeling solutions.
The software allows healthcare providers to easily manipulate material formations and customize the eternal structures of their impressions for patient-specific anatomical models, which are a replication of the patient’s pathological and biological anatomy.
With Digital Anatomy Creator, users will be able to create, explore and share ultra-realistic designs of patient-specific anatomies across communities. They will be able to access additional options and commands to calibrate print media, meeting the requirements of personalized and user-specific anatomical models.
Stratasys has collaborated with Synopsis” SNPS Simpleware ScanIP Medical and MaterializeMTLS Mimics inPrint to certify that its Digital Anatomy and J5 MediJet printers will be included in FDA 510 (k) approved medical modeling workflows. This will give customers access to digital workflows for diagnostic anatomical modeling and improve point-of-care 3D printing.
Recently, Stratasys has extended its materials ecosystem through P3 3D printing systems, Selective Absorption Fusion (“SAF”) and stereolithography. Recently, in November, it launched an Open Material license to advance its manufacturing strategy with a new open level of third-party materials for FDM 3D printers. This has enabled its manufacturing customers to meet new applications with high demands, while having dual material sources.
In October, Stratasys introduced GrabCAD Additive Manufacturing Platform, an open, enterprise-ready software platform that enables manufacturers to manage additive manufacturing operations at the production scale.
In September, the company introduced an Open Material license for the P3-based Origin One, as well as two new materials from Loctite by Henkel. Earlier in June, it extended its software ecosystem with the addition of Teton Simulation, which uses the GrabCAD DFAM software development kit to help customers improve the reliability of additive manufacturing releases.
Stratasys, Ltd. Price Consensus Table | Estimate Stratasys, Ltd.
Zacks rank and actions to consider
Stratasys and Synonpsys currently carry a Zacks Rank # 3 (Hold), while Materialize sports a Zacks Rank # 1 (Strong Buy). Shares of SSYS and SNPS appreciated 30.4% and 37.3%, respectively, while MTLS depreciated 56.1% during the cumulative period (“YTD”).
A higher ranked stock in the wider tech sector includes Advanced micro-systems AMD, which carries a Zacks Rank # 2 (Buy). You can see The full list of today’s Zacks # 1 Rank stocks here.
Zacks ‘consensus estimate for Advanced Micro Devices’ fourth quarter 2021 earnings has been revised up from 8 cents to 76 cents per share in the past 60 days. For 2021, earnings estimates have moved north 15 cents to $ 2.65 per share in the past 60 days.
Profits from Advanced Micro Devices have exceeded Zacks’ consensus estimate in each of the previous four quarters, with an average surprise of 14%. AMD shares rose 76.5% in the YTD period.
Investor Alert: Legal Marijuana Looking for Big Gains?
Now is the time to jump into a young industry poised to skyrocket from $ 13.5 billion in 2021 to $ 70.6 billion expected by 2028.
After a clean sweep of 6 electoral referendums in 5 states, the pot is now legal in 36 states and federal legalization of DC is expected soon and this could launch an even bigger boon for investors. Zacks Investment Research recently closed pot stocks which climbed to + 147.0%.
You are invited to consult Zacks immediately Marijuana Moneymakers: An Investor’s Guide. It presents a timely watchlist of pot stocks and ETFs with exceptional growth potential.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.